CBD 'Highly Promising' In Treatment Of Epileptic Children

Published :
Categories : BlogCBDMedical CannabisScience

CBD 'Highly Promising' In Treatment Of Epileptic Children

The potential of CBD continues to grow, as clinical trials with this popular cannabis extract pump out more positive results.

For a good few years, CBD, one of the non-psychoactive cannabinoids within cannabis, has been touted as a potentially revolutionary way of treating epilepsy. You only need look at the story of Charlotte Figi, whom CBD gave a new lease on life, to understand it is a pretty big deal. Parents with severely epileptic children have been flocking to the states in the USA where CBD has been legalised, in hopes of helping their children. Science has also been keeping pace, working to discover how CBD helps reduce the symptoms of epilepsy, as well as looking deeper into how effective and safe it is. Results thus far have been positive, and they continue to be so, as new clinical trials conclude CBD based treatment is “highly promising” for the treatment of children.

The research, recently published in the journal Seizure, followed 74 participants over three months, analysing the effects CBD had. Each participant had been diagnosed with intractable epilepsy and was resistant to conventional forms of treatment. It was found that using a standardised CBD extract with a 20:1 CBD/THC ratio, 89% of participants encountered a significant reduction in seizure frequency, as well as benefited from improvements to alertness, motor skills, sleep, language and communication.

It was concluded that “the results of this multicenter study on CBD treatment for intractable epilepsy in a population of children and adolescents are highly promising. Further prospective, well-designed clinical trials using enriched CBD medical cannabis are warranted.


This is not the first retrospective clinical trial to look at how CBD has affected those that use it. There have been quite a few others, all finding similar positive results. What this all does is help build a case for further action, as well as affirm the decision of parents who have already decided to use this safe and non-psychoactive compound to try and help their children. As this most recent research suggests, much more thorough clinical trials are warranted. CBD extracts are not considered illegal within the EU and classed as a dietary supplement - as long as they do not contain significant amounts of THC. If successful results continue to arise, it may not be long before we see CBD based extracts take a much more prominent role within society. Onwards and upwards, it would seem!

You can find out more about CBD on our CBD knowledge base.



Written by: Josh
Writer, psychonaut and cannabis aficionado, Josh is Zamnesia’s in-house expert. He spends his days nestled out in the countryside, delving into the hidden depths of all things psychoactive in nature.

      Find out about our writers